Clinical Trials Logo

Bile Reflux clinical trials

View clinical trials related to Bile Reflux.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05369572 Not yet recruiting - Clinical trials for Artificial Intelligence

Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence

Start date: June 30, 2022
Phase:
Study type: Observational

By introducing artificial intelligence into Chinese medicine tongue diagnosis, we collated and collected tongue images, anxiety and depression scales and gastroscopy reports, mined and analysed the correlation between tongue images and bile reflux and anxiety and depression and constructed a prediction model to analyse the possibility of predicting bile reflux and anxiety and depression in patients based on tongue images.

NCT ID: NCT02054637 Not yet recruiting - Clinical trials for Non-acid Reflux Esophagitis

Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

Start date: April 2014
Phase: Phase 2
Study type: Interventional

Somatostatine induces a dose-dependent reduction of postprandial plasma cholecystokinin (CCK) secretion with a concomitant inhibition of postprandial gallbladder contraction, abolishing almost completely bile salts output from the gallbladder. Somatostatine is also known to decrease acid production with significant increase of intragastric pH. In this way, somatostatine could influence acid as well as non-acid reflux by decreasing gallbladder emptying and decreasing acid secretion. Purpose of the study is to evaluate the efficacy of lanreotide autogel 120 mg on symptoms and endoscopic lesions in patients with an endoscopic gastrointestinal reflux esophagitis that cannot be controlled with classic therapy.